Protocol for assessment of capecitabine for advanced colorectal cancer in patients aged 70 years and older (and in a cohort of patients younger than 60 years)
Latest Information Update: 21 Apr 2023
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Pharmacokinetics
- 29 May 2008 Status changed from in progress to completed, as reported on clinicaltrials.gov
- 17 Sep 2005 New trial record.